Neurogenesis Pink Sheet Forward View
| NEUNDelisted Stock | USD 0.0001 0.00 0.00% |
Neurogenesis Pink Sheet outlook is based on your current time horizon.
As of today, the relative strength index (RSI) of Neurogenesis' share price is approaching 33. This indicates that the pink sheet is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Neurogenesis, making its price go up or down. Momentum 33
Sell Stretched
Oversold | Overbought |
Using Neurogenesis hype-based prediction, you can estimate the value of Neurogenesis from the perspective of Neurogenesis response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Neurogenesis on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.000029 and the sum of the absolute errors of 0. Neurogenesis after-hype prediction price | USD 1.25E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Neurogenesis |
Neurogenesis Additional Predictive Modules
Most predictive techniques to examine Neurogenesis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Neurogenesis using various technical indicators. When you analyze Neurogenesis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Neurogenesis Naive Prediction Price Forecast For the 6th of March
Given 90 days horizon, the Naive Prediction forecasted value of Neurogenesis on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.000029, mean absolute percentage error of 0.00000001, and the sum of the absolute errors of 0.Please note that although there have been many attempts to predict Neurogenesis Pink Sheet prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Neurogenesis' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Neurogenesis Pink Sheet Forecast Pattern
| Backtest Neurogenesis | Neurogenesis Price Prediction | Research Analysis |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Neurogenesis pink sheet data series using in forecasting. Note that when a statistical model is used to represent Neurogenesis pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 99.9549 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.1593 |
| SAE | Sum of the absolute errors | 0.0018 |
Predictive Modules for Neurogenesis
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Neurogenesis. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Neurogenesis' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Neurogenesis After-Hype Price Density Analysis
As far as predicting the price of Neurogenesis at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Neurogenesis or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Neurogenesis, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Neurogenesis Estimiated After-Hype Price Volatility
In the context of predicting Neurogenesis' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Neurogenesis' historical news coverage. Neurogenesis' after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered Neurogenesis' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Neurogenesis is very steady at this time. Analysis and calculation of next after-hype price of Neurogenesis is based on 3 months time horizon.
Neurogenesis Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Neurogenesis is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Neurogenesis backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Neurogenesis, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 15 Events / Month | 2 Events / Month | In about 15 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.0001 | 0.0001 | 25.00 |
|
Neurogenesis Hype Timeline
Neurogenesis is now traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Neurogenesis is anticipated to increase in value after the next headline, with the price projected to jump to 1.25E-4 or above. The average volatility of media hype impact on the company the price is insignificant. The price boost on the next news is estimated to be 25.0%, whereas the daily expected return is now at 0.0%. The volatility of related hype on Neurogenesis is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company has a current ratio of 4.36, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Neurogenesis until it has trouble settling it off, either with new capital or with free cash flow. So, Neurogenesis' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Neurogenesis sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Neurogenesis to invest in growth at high rates of return. When we think about Neurogenesis' use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next anticipated press release will be in about 15 days. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.Neurogenesis Related Hype Analysis
Having access to credible news sources related to Neurogenesis' direct competition is more important than ever and may enhance your ability to predict Neurogenesis' future price movements. Getting to know how Neurogenesis' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Neurogenesis may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GSRX | GSRX Industries | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| VIVXF | Avivagen | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SESI | SES Solar | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EAPH | Easton Pharmaceutica | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SAGD | South American Gold | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| WOWU | WOWI Inc | 0.00 | 5 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ADVT | Advantis Corp | (0.15) | 5 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| KKUR | ChromoCure | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CENBF | CEN Biotech | (0.04) | 3 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SWNM | Southwestern Medical Solutions | 0.00 | 4 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Neurogenesis Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Neurogenesis pink sheet to make a market-neutral strategy. Peer analysis of Neurogenesis could also be used in its relative valuation, which is a method of valuing Neurogenesis by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Neurogenesis Market Strength Events
Market strength indicators help investors to evaluate how Neurogenesis pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neurogenesis shares will generate the highest return on investment. By undertsting and applying Neurogenesis pink sheet market strength indicators, traders can identify Neurogenesis entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 | |||
| Relative Strength Index | 33.33 |
Neurogenesis Risk Indicators
The analysis of Neurogenesis' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Neurogenesis' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting neurogenesis pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 26.9 | |||
| Standard Deviation | 111.5 | |||
| Variance | 12433.22 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Neurogenesis
The number of cover stories for Neurogenesis depends on current market conditions and Neurogenesis' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Neurogenesis is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Neurogenesis' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in Neurogenesis Pink Sheet
If you are still planning to invest in Neurogenesis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neurogenesis' history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |